Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00626691 · ClinicalTrials.gov registry record · NA

The Effects of Walnuts on Antioxidant Capacity and Nutritional Status in Humans

A NA study of Healthy, sponsored by Tufts University.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT00626691: Completed NA study of Healthy, sponsored by Tufts University.

NCT00626691 is a NA study of Healthy that has completed, run by Tufts University. The registered enrollment target is 24 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00626691, a NA study of Healthy, has completed, sponsored by Tufts University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to find out if the daily consumption of English walnuts (Juglans regia L.) for 6 wk, at a dose readily incorporated into the diet (0.75 or 1.50 oz), will have a positive effect on antioxidant capacity and nutrient status in a population of healthy adults, aged 50-70 y.

Conditions Studied

Interventions

  • BEHAVIORAL Walnut consumption

Study Locations (1)

Massachusetts

  • Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University - Boston

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2007-02
Est. Completion 2007-12
Phase NA
Tufts University

163 total trials

What the finished NCT00626691 record still lists

NCT00626691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Walnut consumption is the first listed.

NCT00626691 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00626691 about?

NCT00626691 is a clinical study titled "The Effects of Walnuts on Antioxidant Capacity and Nutritional Status in Humans". The goal of this study is to find out if the daily consumption of English walnuts (Juglans regia L.) for 6 wk, at a dose readily incorporated into the diet (0.75 or 1.50 oz), will have a positive effect on antioxidant capacity and nutrient status in a population of healthy adults, aged 50-70 y.

What is the current status of trial NCT00626691?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2007-02. Estimated completion is 2007-12.

What conditions does trial NCT00626691 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00626691?

The interventions under investigation include: Walnut consumption (BEHAVIORAL).

Who is sponsoring clinical trial NCT00626691?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00626691 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00626691's enrollment target sits among peer trials

24 791st of 1090 higher than 254 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00626691, the US trial registry maintained by the National Library of Medicine. NCT00626691 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.